Evidence map›Paper›PMID 36750791›Full record

ArticleBMC cancer2023

Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer.

Zhongzhi Wang, Limeng Qu, Qitong Chen, Yong Zhou, Hongtao Duan, Baifeng Li, Yao Weng, Juan Su, Wenjun Yi

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zhongzhi Wang *Department of General Surgery, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
Limeng Qu *Department of General Surgery, The Second Xiangya Hospital of Central South University, No. 139, Renmin Central Road, Changsha, 410011, P.R. China.
Qitong ChenDepartment of General Surgery, The Second Xiangya Hospital of Central South University, No. 139, Renmin Central Road, Changsha, 410011, P.R. China.
Yong ZhouDepartment of General Surgery, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
Hongtao DuanDepartment of Ultrasound Diagnosis, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
Baifeng LiDepartment of General Surgery, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
Yao WengDepartment of Metabolic Endocrinology, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, Zhuzhou, Hunan, China.
Juan SuDepartment of Medical Administration, the Affiliated Zhuzhou Hospital Xiangya Medical College, Central South University, No.116, Changjiang South Road, Zhuzhou, 412007, P.R. China. 871158782@qq.com.
Wenjun YiDepartment of General Surgery, The Second Xiangya Hospital of Central South University, No. 139, Renmin Central Road, Changsha, 410011, P.R. China. yiwenjun@csu.edu.cn.
Central South University · CN

Funding

Science and Technology Program of Hunan Province 2021SK2026
6 · The paper itself

Abstract

backgroundFew highly accurate tests can diagnose central lymph node metastasis (CLNM) of papillary thyroid cancer (PTC). Genetic sequencing of tumor tissue has allowed the targeting of certain genetic variants for personalized cancer therapy development.

methodsThis study included 488 patients diagnosed with PTC by ultrasound-guided fine-needle aspiration biopsy, collected clinicopathological data, analyzed the correlation between CLNM and clinicopathological features using univariate analysis and binary logistic regression, and constructed prediction models.

resultsBinary logistic regression analysis showed that age, maximum diameter of thyroid nodules, capsular invasion, and BRAF V600E gene mutation were independent risk factors for CLNM, and statistically significant indicators were included to construct a nomogram prediction model, which had an area under the curve (AUC) of 0.778. A convolutional neural network (CNN) prediction model built with an artificial intelligence (AI) deep learning algorithm achieved AUCs of 0.89 in the training set and 0.78 in the test set, which indicated a high prediction efficacy for CLNM. In addition, the prediction models were validated in the subclinical metastasis and clinical metastasis groups with high sensitivity and specificity, suggesting the broad applicability of the models. Furthermore, CNN prediction models were constructed for patients with nodule diameters less than 1 cm. The AUCs in the training set and test set were 0.87 and 0.76, respectively, indicating high prediction efficacy.

conclusionsThe deep learning-based multifeature integration prediction model provides a reference for the clinical diagnosis and treatment of PTC.

Indexed as

Deep LearningThyroid NeoplasmsArtificial IntelligenceHumansLymphatic MetastasisLymph NodesRetrospective StudiesRisk FactorsThyroid Cancer, PapillaryBRAF V600E gene mutationCentral lymph node metastasis(CLNM)Convolutional neural network(CNN)Papillary thyroid cancer(PTC)

Identifiers

PMID36750791
PMCPMC9906958
OpenAlexW4319461886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.